The Vivinex multiSert from Hoya Corp. - preloaded lens for quieter cataract surgery

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-30, 04:12. Details in the imprint.

The Vivinex multiSert system from Hoya sits on a steel tray next to the operating microscope, a small clear cartridge holding the folded intraocular lens that will replace a cloudy human lens in minutes. Surgeons describe the injector as tidy in the hand and predictably smooth in the wound.

What Vivinex multiSert does

Vivinex multiSert is a preloaded intraocular lens system that combines Hoya's hydrophobic acrylic Vivinex IOL with a single-use injector for cataract surgery. The design aims to reduce handling of the lens and to lower the risk of contamination inside the operating field.

The lens itself is made from a hydrophobic acrylic material with a square-edge design that helps limit posterior capsule opacification, the secondary clouding that often sends patients back for laser treatment. Surgeons report a convincing level of clarity under the microscope once the lens unfolds in the capsular bag.

Injector feel in the hand

Surgeons like Dr. Kenji Takahashi in Tokyo describe the Vivinex multiSert injector as quiet in the wound, with a controlled plunger feel that lets the lens slide rather than jump into the eye. In his account, the compact tip fits through a small corneal incision without forcing.

Because the lens is preloaded at the factory, the scrub nurse does not have to dial up forceps and fold the IOL chair-side, which cuts down on manipulation and speeds up turnover between patients. The operating room feels less cluttered, with fewer tools on the tray and a clearer workflow.

Optical performance and options

Hoya offers Vivinex lenses in a range of diopters to match different patient eyes, from low to high powers for strong prescriptions. Some models come in toric variants to correct astigmatism, letting the surgeon align marks on the lens with the patient's corneal axis.

The optical design focuses on sharp central vision for distance, and in monofocal form it does not add near focus zones, so patients often still wear reading glasses. In practice, many older patients accept this trade-off as consistent and predictable rather than chasing spectacle independence.

Where it fits in Hoya's lineup

Within Hoya's medical portfolio, Vivinex multiSert sits alongside other intraocular lenses and endoscopy products that share similar polymer and optics know-how. The company uses its long experience in precision polishing and coatings from eyeglass lenses to refine the surface quality of surgical IOLs.

The multiSert system gives Hoya a practical answer to rival preloaded lens systems from other manufacturers, positioning the group as a serious player in day-surgery cataract markets across Europe and Asia. Hospitals can standardize on one platform and benefit from consistent packaging and training.

Context and Hoya shares

Hoya Corp, based in Tokyo, generates a significant share of its revenue from life-care products such as eyeglass lenses, endoscopes and intraocular lenses, alongside its data and electronics segment. For investors, the Vivinex multiSert system is one element in that broader medical growth story. Hoya Corp shares (ISIN JP3837800006) trade on the Tokyo Stock Exchange, with the Hoya Corp share price quoted in Japanese yen.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | JP3837800006 | HOYA | boerse | 69656539 | bgmi